Skip to Main Content

Advertisement

Skip Nav Destination

Tisagenlecleucel Is Safe and Effective in Relapsed/Refractory Follicular Lymphoma

Cancer Discov (2022) 12 (3): OF4.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal